Publications hub
Search our publications, laboratory reports, meeting statements, scheduling submissions and scheduling decisions.
We’re still confirming the best location for some of our content. Can't find what you’re looking for? You can also:
- search our Resources
- use the site search bar in the top right of this screen for more results.
Loading...
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
- Advisory bodies and committees (18)
- Scheduling (national classification system) (11)
- Therapeutic goods regulation (6)
- Prescription medicines (4)
- Medicine safety (3)
- Advertising (2)
- Legislation (2)
- Manufacturing (2)
- Medicinal cannabis hub (2)
- Non-prescription medicines (2)
- Shortages (2)
- Australian Register of Therapeutic Goods (ARTG) (1)
- Biological medicines (1)
- Breast implant hub (1)
- Cosmetics (1)
- Fees and payments (1)
- Import and export (1)
- Registered complementary medicines (1)
- Regulatory compliance (1)
Search
38 result(s) found, displaying 1 to 25
-
Meeting statementsAdvisory Committee on Complementary Medicines meeting statement for 14 March 2024
-
Scheduling decisions (final)This web publication constitutes a notice for the purposes of regulations 42ZCZS and 42ZCZX of the Therapeutic Goods Regulations 1990 (the Regulations).
-
Scheduling decisions (interim)We are seeking submissions for a consultation on the interim decisions for IV potassium salts and nicotinic acid.
-
PublicationsRead our 2024 stakeholder survey report, which aims to improve the way we work with our stakeholders.
-
Meeting statementsCommunique from the meeting of the TGACC
-
PublicationsWe commissioned the Health Design Lab to conduct market research to better understand the individual consumer, pharmacist and prescriber experiences of shortages and discontinuations.
-
Meeting statementsRead the meeting statement from 10 October 2024 meeting of the Advisory Committee on Medical Devices
-
Meeting statementsA meeting statement from the second meeting of the Point-of-care Manufacturing of Medical Devices Steering Committee is now available.
-
Meeting statementsFind out about the AIVC Recommendations for the Composition of Influenza Vaccines for Australia in 2025.
-
Scheduling submissionsFind out about the public submissions on interim decisions for scheduling matters referred to the ACMS #44, ACCS #38 and Joint ACMS-ACCS #36 meetings held in March 2024
-
Scheduling decisions (final)This web publication constitutes a notice for the purposes of regulations 42ZCZS and 42ZCZX of the Therapeutic Goods Regulations 1990 (the Regulations).
-
Scheduling decisions (final)Publication of the decisions made by a delegate of the Secretary in relation to glycopyrronium and palmitoylethanolamide.
-
Scheduling decisions (interim)Interim decisions on proposed amendments to the Poisons Standard closing 18 October 2024.
-
Scheduling decisions (final)This publication is a notice of decision made by a delegate of the Secretary of the Department of Health and Aged Care under regulation 42ZCZX of the Therapeutic Goods Regulations 1990, and the reasons for the decision.
-
Meeting statementsCommunique from the 7th meeting of the WHPWG 30 July 2024
-
Meeting statementsThe 80th meeting of the Advisory Committee on Medical Devices (ACMD), 8 August 2024.
-
PublicationsFind out how we are managing shortages of medicines and taking action to limit their effects. Read our 2024 report.
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
Scheduling submissionsFind out about the public submissions on scheduling matters referred to the ACMS #44, ACCS #38 and Joint ACMS-ACCS #36 meetings held in March 2024
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
PublicationsThis Cost Recovery Implementation Statement (CRIS) 2024-2025 provides information on how we implement, and cost recover our regulatory activities.
-
Meeting statementsCommunique from the 6th meeting of the WHPWG, 27 March 2024
-
TGA laboratory testing reportsMedicinal cannabis products are permitted to be supplied into Australia under the Special Access Scheme, by authorised prescribers, and/or for use in clinical trials.
-
PublicationsThis framework outlines our processes to identify and manage risk relating to breast implants.
-
PublicationsThis fact sheet is for healthcare practitioners to help understand the rules surrounding importation of cosmetic injectables.